Liver fibrosis scores couldbe used for predicting adverse outcomes in patients with STEMI

Announcing a new article publication for Cardiovascular Innovations and Applications journal. Liver fibrosis scores (LFSs) are novel tools for predicting cardiovascular events in patients with coronary artery disease.

Closed-loop system appears to be safe and superior to usual care in controlling glucose in children with type 1 diabetes

Closed-loop insulin delivery systems improve glucose control in children with type 1 diabetes without causing adverse effects, according to a study presented Saturday at ENDO

June 18, 2023

Chinese imports of common cancer drug run dry, FDA says

China’s Qilu Pharmaceutical has distributed all of the chemotherapy cisplatin that was imported as a result of the shortage of the common cancer drug. The

September 20, 2023

Michelle Tarver to lead FDA medical device center

Michelle Tarver will be the new leader of the medical devices center at the Food and Drug Administration, according to an email reviewed by STAT

October 22, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.